Tianjin Tianyao Pharmaceuticals Co Ltd (600488) — Cash Flow-to-Debt Ratio
Tianjin Tianyao Pharmaceuticals Co Ltd (600488) has a Cash Flow-to-Debt Ratio of 0.01x as of September 2025, meaning its operating cash flow of CN¥13.19 Million could theoretically repay 0% of its total liabilities (CN¥1.85 Billion) in one year. See 600488 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Tianjin Tianyao Pharmaceuticals Co Ltd Cash Flow-to-Debt Ratio (2000–2024)
Historical debt coverage capacity for Tianjin Tianyao Pharmaceuticals Co Ltd across 25 annual periods. Also explore 600488 year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Tianjin Tianyao Pharmaceuticals Co Ltd (2000–2024)
Year-by-year debt coverage analysis for Tianjin Tianyao Pharmaceuticals Co Ltd. For market capitalisation and broader financial context, see 600488 market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.31x | CN¥569.37 Million | CN¥1.81 Billion | ▼ -4.1% |
| 2023 | 0.33x | CN¥783.01 Million | CN¥2.39 Billion | ▲ +45.3% |
| 2022 | 0.23x | CN¥653.52 Million | CN¥2.90 Billion | ▲ +80.0% |
| 2021 | 0.13x | CN¥316.89 Million | CN¥2.53 Billion | ▼ -13.2% |
| 2020 | 0.14x | CN¥346.88 Million | CN¥2.40 Billion | ▼ -12.4% |
| 2019 | 0.16x | CN¥279.37 Million | CN¥1.70 Billion | ▲ +32.2% |
| 2018 | 0.12x | CN¥189.27 Million | CN¥1.52 Billion | ▲ +1865.8% |
| 2017 | -0.01x | CN¥-8.15 Million | CN¥1.15 Billion | ▼ -105.7% |
| 2016 | 0.12x | CN¥63.32 Million | CN¥511.21 Million | ▼ -44.1% |
| 2015 | 0.22x | CN¥129.50 Million | CN¥584.42 Million | ▼ -37.9% |
| 2014 | 0.36x | CN¥178.76 Million | CN¥501.34 Million | ▲ +231.3% |
| 2013 | 0.11x | CN¥84.55 Million | CN¥785.64 Million | ▲ +489.2% |
| 2012 | 0.02x | CN¥13.23 Million | CN¥724.13 Million | ▼ -83.0% |
| 2011 | 0.11x | CN¥78.47 Million | CN¥729.86 Million | ▲ +18.6% |
| 2010 | 0.09x | CN¥116.82 Million | CN¥1.29 Billion | ▼ -77.8% |
| 2009 | 0.41x | CN¥435.13 Million | CN¥1.07 Billion | ▲ +98.5% |
| 2008 | 0.21x | CN¥219.31 Million | CN¥1.07 Billion | ▲ +8.1% |
| 2007 | 0.19x | CN¥162.33 Million | CN¥854.65 Million | ▲ +404.7% |
| 2006 | 0.04x | CN¥50.72 Million | CN¥1.35 Billion | ▲ +132.3% |
| 2005 | -0.12x | CN¥-108.87 Million | CN¥933.43 Million | ▼ -157.2% |
| 2004 | 0.20x | CN¥110.30 Million | CN¥541.10 Million | ▲ +198.1% |
| 2003 | 0.07x | CN¥45.77 Million | CN¥669.25 Million | ▼ -4.2% |
| 2002 | 0.07x | CN¥45.28 Million | CN¥634.50 Million | ▼ -58.4% |
| 2001 | 0.17x | CN¥71.87 Million | CN¥419.39 Million | ▲ +21.5% |
| 2000 | 0.14x | CN¥41.06 Million | CN¥291.03 Million | — |